📋 FDA Reference

Contour Se Microspheres Syringe

Boston Scientific Corporation

Contact Boston Scientific Corporation ↗ Compare similar devices

Summary: The Contour SE Microspheres Syringe is a medical device used for embolization procedures. It is typically utilized by interventional radiologists to treat conditions such as uterine fibroids and arteriovenous malformations.

FDA Clearance Information

Pathway ? 510(k)
Number ? K032707 ↗
Decision Date ? September 23, 2003
Product Code ? HCG Device, Neurovascular Embolization
Device Class ? Class 2
Evidence ? 0 studies

The Contour SE Microspheres Syringe was cleared through the FDA 510(k) pathway on September 23, 2003. It is manufactured by Boston Scientific and is classified as a Class 2 medical device.

What It Is

The Contour SE Microspheres Syringe is designed for embolization, a procedure that blocks blood flow to specific areas. The device consists of biocompatible microspheres that are injected into the bloodstream to occlude blood vessels. This technique is often used to reduce blood supply to tumors or to control bleeding.

FDA-Cleared Indications

  • Embolization of blood vessels in the peripheral vasculature.
  • Use as an embolic material during indicated interventional radiology procedures.
  • The specific treated condition, vessel, microsphere size, and delivery technique must follow the device labeling and treating physician's judgment.

Clinical Applications

  • Catheter-directed embolization of selected peripheral blood vessels.
  • Uterine artery embolization for appropriately selected patients with symptomatic uterine fibroids, when consistent with the product labeling.
  • Embolization of selected vascular lesions or bleeding vessels when the procedure is within the cleared labeling.
  • Reduction of blood flow to a targeted vascular territory using image-guided catheter delivery.

Reported off-label uses

  • Embolization of selected hypervascular tumors.
  • Embolization of selected arteriovenous malformations.
  • Embolization of other vascular bleeding or malformation sites not specifically listed in the cleared indication.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • Microsphere size should be selected for the target vessel, vascular anatomy, desired level of occlusion, and embolization objective.
  • Delivery requires a compatible catheter and fluoroscopic or other appropriate imaging guidance; injection should be performed slowly and carefully to reduce the risk of nontarget embolization.
  • Contraindications and precautions include uncorrectable coagulopathy, severe vasospasm, vessel anatomy that cannot safely accommodate the catheter, significant unresolvable arterial shunting, and known hypersensitivity to relevant materials or contrast media.
  • MRI safety depends on the specific product labeling and the materials used; the device record alone should not be treated as confirmation that every component is MR Safe or MR Conditional.
  • Embolization is generally intended to produce durable vessel occlusion, but recanalization, collateral blood flow, or disease progression may lead to recurrent symptoms or require additional treatment.

Frequently Asked Questions

What is Contour SE Microspheres Syringe used for?

It is used for embolization procedures to block blood vessels in conditions like uterine fibroids and tumors.

What specialties typically use this device?

Interventional radiologists commonly use this device in hospital settings.

What are the FDA-cleared indications?

The device is indicated for embolization to occlude blood vessels in conditions such as uterine fibroids and certain tumors.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you